Hybrid Robot+FES Stroke Rehablitation

Sponsor
University of Maryland, Baltimore (Other)
Overall Status
Recruiting
CT.gov ID
NCT04550728
Collaborator
(none)
60
1
2
65
0.9

Study Details

Study Description

Brief Summary

The investigators have developed a novel robot-guided stretching under intelligent control and combine it with active movement training, which helped increase joint ROM, reduce spasticity and joint stiffness, increase muscle force output, and improve locomotion. However, for stroke survivors with sensorimotor impairment, their peripheral muscle may not sufficiently be recruited. Functional electrical stimulation (FES), has been shown its advantage to activate the peripheral muscles for people with neurological conditions. The investigators thus make a hybrid robot-FES rehabilitation system, combining the advantage of robot and FES technologies for stroke motor recovery. The investigators further would like to translate the technologies from lab to home-based training. Thus, the investigators will conduct a randomized, controlled, primarily home-based clinical trial using an ankle robot alone or combined with functional electrical stimulation (FES) to treat sensorimotor and locomotion impairments post-stroke.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Ankle robot training group
  • Combination Product: Ankle robot training and functional electrical stimulation(FES) group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Assessment Followed by Home-based Hybrid Robot + FES Rehabilitation Post-stroke
Actual Study Start Date :
Aug 1, 2021
Anticipated Primary Completion Date :
Oct 1, 2026
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: FES+robot

Participants in this group will have FES during ankle robot training

Combination Product: Ankle robot training and functional electrical stimulation(FES) group
Patients will use the ankle robot device as the ankle training group. Also, water-based FES electrodes positioned inside a soft garment will be secured over the DF and PF muscles by wrapping the garment around the leg just below the knee joint. Stimulation intensity will be increased to maximal tolerance of each participant. Electrically induced contraction timing will be triggered by the ankle robot in synchrony with the ankle dorsi and plantar flexion movements.

Active Comparator: Robot

Participants in this group will have ankle robot training only

Combination Product: Ankle robot training group
Patients will be seated with the paretic foot strapped to the footplate the knee at full extension. The operator will set up and measure (using the robot) ankle passive DF and PF ROM limits. The robot training will include passive stretching, robot interactive game-based training, and cool-down stretching.

Outcome Measures

Primary Outcome Measures

  1. Fugl-Meyer Lower Extremity [Baseline]

    The assessment is a measure of lower extremity (LE) motor and sensory impairments post-stroke.

  2. Fugl-Meyer Lower Extremity [6 weeks]

    The assessment is a measure of lower extremity (LE) motor and sensory impairments post-stroke.

  3. Fugl-Meyer Lower Extremity [12 weeks]

    The assessment is a measure of lower extremity (LE) motor and sensory impairments post-stroke.

  4. Dorsiflexion active range of motion [Baseline]

    Joint ankle active range of motion measured by ankle robot.

  5. Dorsiflexion active range of motion [6 weeks]

    Joint ankle active range of motion measured by ankle robot.

  6. Dorsiflexion active range of motion [12 weeks]

    Joint ankle active range of motion measured by ankle robot.

  7. 6 minutes walking test [Baseline]

    The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.

  8. 6 minutes walking test [6 weeks]

    The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.

  9. 6 minutes walking test [12 weeks]

    The six-minute walk test (6MWT) measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface. The goal is for the individual to walk as far as possible in six minutes.

  10. Medical thickness of medial gastrocnemius muscle and tibial anterior muscle [Baseline]

    B-model ultrasound will be used to scan the muscle thickness, and the image will be further proceeded to measure the muscle thickness with unit in centimetres.

  11. Medical thickness of medial gastrocnemius muscle and tibial anterior muscle [6 week]

    B-model ultrasound will be used to scan the muscle thickness, and the image will be further proceeded to measure the muscle thickness with unit in centimetres.

  12. Medical thickness of medial gastrocnemius muscle and tibial anterior muscle [12 week]

    B-model ultrasound will be used to scan the muscle thickness, and the image will be further proceeded to measure the muscle thickness with unit in centimetres.

  13. Muscle fiber penation angle of medial gastrocnemius muscle and tibial anterior muscle [Baseline]

    B-model ultrasound will be used to scan the muscle and the image will be further proceeded to measure the muscle fiber penation angle with unit in degree.

  14. Muscle fiber penation angle of medial gastrocnemius muscle and tibial anterior muscle [6 week]

    B-model ultrasound will be used to scan the muscle and the image will be further proceeded to measure the muscle fiber penation angle with unit in degree.

  15. Muscle fiber penation angle of medial gastrocnemius muscle and tibial anterior muscle [12 week]

    B-model ultrasound will be used to assess the muscle thickness, muscle fiber pennation angle. Elasticity will be measured using ultrasound elastography.

Secondary Outcome Measures

  1. Timed up-to-go [Baseline]

    The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

  2. Timed up-to-go [6 weeks]

    The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

  3. Timed up-to-go [12 weeks]

    The Timed Up and Go test (TUG) is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

  4. Stroke Rehabilitation Assessment of Movement (STREAM) [baseline]

    Stroke Rehabilitation Assessment of Movement Measure (STREAM) provides therapists with a quantitative measurement of motor functioning and basic mobility deficits among patients who had a stroke through the performance of 30 voluntary motor tasks of the upper extremities (UE) and lower extremities (LE).

  5. Stroke Rehabilitation Assessment of Movement (STREAM) [6 weeks]

    Stroke Rehabilitation Assessment of Movement Measure (STREAM) provides therapists with a quantitative measurement of motor functioning and basic mobility deficits among patients who had a stroke through the performance of 30 voluntary motor tasks of the upper extremities (UE) and lower extremities (LE).

  6. Stroke Rehabilitation Assessment of Movement (STREAM) [12 weeks]

    Stroke Rehabilitation Assessment of Movement Measure (STREAM) provides therapists with a quantitative measurement of motor functioning and basic mobility deficits among patients who had a stroke through the performance of 30 voluntary motor tasks of the upper extremities (UE) and lower extremities (LE).

  7. Brief Balance Evaluation Systems Test(Brief-BESTest) [baseline]

    The Brief BESTest is a clinical balance assessment tool. It is an abbreviated version of Balance Evaluation Systems Test (BESTest), designed to assess 6 different aspects contributing to postural control in standing and walking.

  8. Brief Balance Evaluation Systems Test(Brief-BESTest) [6 weeks]

    The Brief BESTest is a clinical balance assessment tool. It is an abbreviated version of Balance Evaluation Systems Test (BESTest), designed to assess 6 different aspects contributing to postural control in standing and walking.

  9. Brief Balance Evaluation Systems Test(Brief-BESTest) [12 weeks]

    The Brief BESTest is a clinical balance assessment tool. It is an abbreviated version of Balance Evaluation Systems Test (BESTest), designed to assess 6 different aspects contributing to postural control in standing and walking.

  10. Modified Ashworth Scale (MAS) [baseline]

    The Modified Ashworth Scale is the most widely used assessment tool to measure resistance to limb movement in a clinic setting. Scores range from 0-4, with 6 choices. 0 (0) - No increase in muscle tone; 1 (1) - Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension; 1+ (2) - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of movement (ROM); 2 (3) - More marked increase in muscle tone through most of the ROM, but affect part(s) easily moved; 3 (4) - Considerable increase in muscle tone passive, movement difficult; 4 (5) - Affected part(s) rigid in flexion or extension.

  11. Modified Ashworth Scale (MAS) [6 weeks]

    The Modified Ashworth Scale is the most widely used assessment tool to measure resistance to limb movement in a clinic setting. Scores range from 0-4, with 6 choices. 0 (0) - No increase in muscle tone; 1 (1) - Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension; 1+ (2) - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of movement (ROM); 2 (3) - More marked increase in muscle tone through most of the ROM, but affect part(s) easily moved; 3 (4) - Considerable increase in muscle tone passive, movement difficult; 4 (5) - Affected part(s) rigid in flexion or extension.

  12. Modified Ashworth Scale (MAS) [12 weeks]

    The Modified Ashworth Scale is the most widely used assessment tool to measure resistance to limb movement in a clinic setting. Scores range from 0-4, with 6 choices. 0 (0) - No increase in muscle tone; 1 (1) - Slight increase in muscle tone, manifested by a catch and release or by minimal resistance at the end of the range of motion when the affected part(s) is moved in flexion or extension; 1+ (2) - Slight increase in muscle tone, manifested by a catch, followed by minimal resistance throughout the remainder (less than half) of the range of movement (ROM); 2 (3) - More marked increase in muscle tone through most of the ROM, but affect part(s) easily moved; 3 (4) - Considerable increase in muscle tone passive, movement difficult; 4 (5) - Affected part(s) rigid in flexion or extension.

  13. 10-meter walk test (10MWT) [baseline]

    The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.

  14. 10-meter walk test (10MWT) [6 weeks]

    The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.

  15. 10-meter walk test (10MWT) [12 weeks]

    The 10 Metre Walk Test is a performance measure used to assess walking speed in metres per second over a short distance. It can be employed to determine functional mobility, gait, and vestibular function.

  16. Stiffness of medial gastrocnemius muscle and tibial anterior muscle. [Baseline]

    Supersonic shear wave elastography will be used to estimate the shear wave speed(m/s) of the muscles.

  17. Stiffness of medial gastrocnemius muscle and tibial anterior muscle. [6 weeks]

    Supersonic shear wave elastography will be used to estimate the shear wave speed(m/s) of the muscles.

  18. Stiffness of medial gastrocnemius muscle and tibial anterior muscle. [12 weeks]

    Supersonic shear wave elastography will be used to estimate the shear wave speed(m/s) of the muscles.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-85;

  • Able to ambulate at least 10 meters without human assistance, with or without an assistive device

  • ≥ 6 months post stroke;

  • having a caregiver to assist in training at home.

Exclusion Criteria:
  • having expressive and receptive aphasia;

  • an inability to follow multi-step commands;

  • enrolled in another lower limb rehabilitation program;

  • having severe pain in the paralyzed lower-limb;

  • 30º ankle plantar flexion contracture;

  • Having implanted electronic device such as a pacemaker, spinal cord, or deep brain stimulator because FES may potentially interfere with their functions.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Maryland School of Medicine Baltimore Maryland United States 21201

Sponsors and Collaborators

  • University of Maryland, Baltimore

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Li-Qun Zhang, Professor, University of Maryland, Baltimore
ClinicalTrials.gov Identifier:
NCT04550728
Other Study ID Numbers:
  • HP-00089895
First Posted:
Sep 16, 2020
Last Update Posted:
Aug 12, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Li-Qun Zhang, Professor, University of Maryland, Baltimore
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 12, 2021